Molnupiravir, Nirmatrelvir/Ritonavir, or Sotrovimab for High-Risk COVID-19 Patients Infected by the Omicron Variant: Hospitalization, Mortality, and Time until Negative Swab Test in Real Life

• Автори: Luca Cegolon (Автор), Riccardo Pol (Автор), Omar Simonetti (Автор), Francesca Larese Filon (Автор), Roberto Luzzati (Автор)
• Формат: Книга
• Опубліковано: MDPI AG, 2023-05-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

<b>Background</b>. Several drugs which are easy to administer in outpatient settings have been authorized and endorsed for high-risk COVID-19 patients with mild-moderate disease to prevent hospital admission and death, complementing COVID-19 vaccines. However, the evidence on the efficac...